The China deal might have forced a short-term deto
Post# of 36536
(Total Views: 288)
Posted On: 03/03/2020 5:09:50 PM
The China deal might have forced a short-term detour on the S-1 for NGIO. Since you kind of have to strike while the iron's hot, that is understandable.
The funding S-1 is in the hands of the SEC - again, I believe they stated they try to comment or approve within 30 days. So that time line is not quite finished yet.
Finally, the initial China PR said there were to be "other announcements" at the signing ceremony in China. Maybe they will have to do with NGIO; maybe they will address a diagnostic kit; maybe they'll announce the Altucell closing; maybe I'm FOS! But we'll probably know by Thursday at latest; possibly tomorrow with the time difference between New York and China.
The funding S-1 is in the hands of the SEC - again, I believe they stated they try to comment or approve within 30 days. So that time line is not quite finished yet.
Finally, the initial China PR said there were to be "other announcements" at the signing ceremony in China. Maybe they will have to do with NGIO; maybe they will address a diagnostic kit; maybe they'll announce the Altucell closing; maybe I'm FOS! But we'll probably know by Thursday at latest; possibly tomorrow with the time difference between New York and China.
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼